| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,062 |
4,838 |
$1.36M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,362 |
2,262 |
$887K |
| 80053 |
Comprehensive metabolic panel |
3,795 |
3,086 |
$342K |
| H2035 |
Alcohol and/or other drug treatment program, per hour |
3,061 |
569 |
$236K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,554 |
2,489 |
$208K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
401 |
387 |
$203K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,573 |
1,432 |
$134K |
| 36415 |
Collection of venous blood by venipuncture |
15,023 |
13,361 |
$126K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,795 |
3,065 |
$113K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
367 |
360 |
$76K |
| J3490 |
Unclassified drugs |
10,397 |
4,935 |
$69K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
640 |
620 |
$50K |
| 85027 |
|
1,988 |
1,894 |
$41K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,584 |
3,022 |
$36K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
545 |
537 |
$31K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,891 |
1,840 |
$30K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
536 |
490 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
236 |
226 |
$23K |
| Q3014 |
Telehealth originating site facility fee |
1,795 |
1,632 |
$19K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
244 |
232 |
$16K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
300 |
282 |
$16K |
| 86140 |
|
682 |
642 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
94 |
73 |
$15K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
13 |
$14K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
961 |
893 |
$12K |
| 81015 |
|
1,678 |
1,224 |
$11K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
119 |
49 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
315 |
174 |
$11K |
| J7050 |
Infusion, normal saline solution, 250 cc |
674 |
186 |
$6K |
| 85018 |
|
776 |
717 |
$6K |
| 84512 |
|
125 |
115 |
$6K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
39 |
38 |
$5K |
| 86780 |
|
175 |
164 |
$5K |
| 73630 |
|
47 |
36 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
64 |
55 |
$5K |
| 59025 |
Fetal non-stress test |
17 |
12 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
92 |
91 |
$4K |
| 83735 |
|
270 |
250 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
92 |
91 |
$4K |
| 81001 |
|
334 |
319 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
27 |
27 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
198 |
191 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
58 |
26 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
13 |
13 |
$3K |
| 85610 |
|
173 |
141 |
$2K |
| 83880 |
|
29 |
29 |
$2K |
| 84484 |
|
60 |
40 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
41 |
41 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
63 |
61 |
$1K |
| 74018 |
|
12 |
12 |
$1K |
| 87081 |
|
124 |
118 |
$1K |
| 87150 |
|
12 |
12 |
$1K |
| 83605 |
|
51 |
41 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
36 |
35 |
$1K |
| 86850 |
|
39 |
37 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
23 |
15 |
$895.00 |
| 83655 |
|
70 |
63 |
$835.47 |
| 84145 |
|
13 |
12 |
$770.85 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
14 |
$747.59 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
22 |
14 |
$683.73 |
| 11721 |
|
81 |
60 |
$625.70 |
| 81003 |
|
57 |
54 |
$466.44 |
| 80061 |
Lipid panel |
12 |
12 |
$432.06 |
| 86787 |
|
13 |
12 |
$377.32 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$359.95 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
12 |
$350.93 |
| 86762 |
|
13 |
12 |
$342.08 |
| 84702 |
|
14 |
12 |
$340.25 |
| 86803 |
|
13 |
12 |
$337.38 |
| J2704 |
Injection, propofol, 10 mg |
14 |
12 |
$334.19 |
| 84100 |
|
30 |
28 |
$320.72 |
| 87340 |
|
13 |
12 |
$312.86 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
26 |
$305.94 |
| 86900 |
|
13 |
12 |
$262.53 |
| 86901 |
|
13 |
12 |
$262.17 |
| 81025 |
|
14 |
13 |
$190.52 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16 |
15 |
$152.86 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$137.18 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
12 |
12 |
$134.27 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$97.80 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$6.77 |